Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials - Griffiths, C E; Reich, K; Lebwohl, M (Lancet, 2015)
et al.